FCMI

Foresite Capital Management IV Portfolio holdings

AUM $124M
1-Year Est. Return 24.36%
This Quarter Est. Return
1 Year Est. Return
-24.36%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$111M
AUM Growth
+$2.27M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
5
New
Increased
Reduced
Closed

Top Buys

1
+$23.3M
2
+$4.13M
3
+$199K

Top Sells

1
+$4.06M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PHVS icon
1
Pharvaris
PHVS
$1.52B
$69.2M 62.35%
4,410,581
+12,700
MAZE
2
Maze Therapeutics
MAZE
$1.43B
$23.3M 20.93%
+2,111,919
LYEL icon
3
Lyell Immunopharma
LYEL
$328M
$8.61M 7.75%
800,400
+384,150
KURA icon
4
Kura Oncology
KURA
$847M
$7.34M 6.61%
1,111,882
-615,000
RLAY icon
5
Relay Therapeutics
RLAY
$1.22B
$2.62M 2.36%
1,000,000